Flynn James E

10% OwnerParabilis Medicines, Inc. (PBLS) · full profile →Form 4 · filed Jun 12, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
16
8 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Conversion(C)123K123K
Jun 11, 2026Conversion(C)123K123K
Jun 11, 2026Conversion(C)149K272K
Jun 11, 2026Conversion(C)149K272K
Jun 11, 2026Conversion(C)261K533K
Jun 11, 2026Conversion(C)261K533K
Jun 11, 2026Conversion(C)407K940K
Jun 11, 2026Conversion(C)407K940K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2026Conversion(C)166K0
Jun 11, 2026Conversion(C)166K0
Jun 11, 2026Conversion(C)144K0
Jun 11, 2026Conversion(C)144K0
Jun 11, 2026Conversion(C)247K0
Jun 11, 2026Conversion(C)247K0
Jun 11, 2026Conversion(C)465K0
Jun 11, 2026Conversion(C)465K0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-26-000798) within minutes of acceptance. Every field above traces to the original document. Verify it directly: